Abiopharma

Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 2 at the Increased Dose of 10 mg/kg in Entrada Therapeutics’ ELEVATE-45-201 Study

Bioventus to Present at the Goldman Sachs 47TH Annual Global Healthcare Conference

Aben Gold Announces Up to $1.5 million Non-Brokered Flow-Through Private Placement

BeyondSpring Presents the Latest Update of a Phase 2 Study Demonstrating Durable Clinical Benefit of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic NSCLC After Progression on First-Line Immune Checkpoint Inhibitor Therapy at ASCO 2026

Opus Genetics to Host Virtual R&D Science Forum on Tuesday, June 16, 2026 Featuring Multiple Inherited Retinal Disease Experts

SM Energy to Participate in Upcoming Investor Conference

NIQ Launches Product Intelligence to Power AI-Driven Commerce

Picard Medical / SynCardia Advances Emperor Total Artificial Heart Program with Successful Next-Generation Preclinical Implant Studies

Arxis Announces Acquisitions of Omnetics Connector Corporation and MagCanica Inc.

X-energy Submits Xe-100 HTGR for UK Generic Design Assessment